Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close

The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested.

The Associated Press February 01, 2021 15:24:53 IST
Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close

Equitable distribution of vaccines is in every country’s economic interest, especially those that depend most on trade. It amounts to a rebuke to the popular notion that sharing vaccines with poor countries is merely a form of charity. Image Credit: Pixabay

While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe. Some use tried-and-true technologies, other use novel approaches. The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested. How well they work varies, with preliminary study results ranging from 50% effective to over 90%. So far, regulators in different countries have allowed use of about a half dozen, mostly under emergency use provisions. A few more are getting close. The ones available now all require two doses, given weeks apart.

Pfizer Moderna Astrazeneca Bharat Biotech other COVID19 vaccines in use or getting close

Among those furthest along:

Pfizer: Developed with BioNTech; authorized by the U.S., U.K, European Union, the World Health Organization and elsewhere.

Moderna: Developed with the U.S. National Institutes of Health; authorized by the U.S., U.K., European Union, the World Health Organization and elsewhere.

AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.

Sputnik V: Developed by Russia's Gamaleya Research Institute; authorized in Russia and about 10 other countries.

Sinopharm: Authorized in China and several countries including Hungary, Serbia, and Morocco.

Sinovac: Authorized in China as well as Turkey, Brazil and Indonesia.

Bharat Biotech: Authorized in India.

Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization soon.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

FDA approves storage of Pfizer COVID-19 vials at normal freezer temperature
World

FDA approves storage of Pfizer COVID-19 vials at normal freezer temperature

Once thawed, the vials can be stored at fridge temperatures of 2 to 8 degrees Celsius for up to five days, it clarified.

South Korea administers first COVID-19 shots to people at long-term care facilities
World

South Korea administers first COVID-19 shots to people at long-term care facilities

The government has also decided to extend current social distancing levels for at least another two weeks.

Johnson & Johnson's single-dose COVID-19 vaccine safe and effective, says FDA paving way for approval
World

Johnson & Johnson's single-dose COVID-19 vaccine safe and effective, says FDA paving way for approval

The vaccine was 66.1% effective in preventing moderate to severe disease and appeared safe, the US Food and Drug Administration said on Wednesday